Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

antidote

- PMLiVE

Swedish regulator rules Boehringer press release is advertising

German pharma company fails to appeal decision

- PMLiVE

Boehringer launches COPD patient consultation app for HCPs

Extends reach of the calculator tools on its COPD Exchange website

- PMLiVE

Boehringer and Lilly close in on empagliflozin filing

But amend diabetes alliance after Boehringer drops basal insulin

- PMLiVE

Pharma’s 2012 in … gamification

Boehringer’s headline-grabbing Syrum wasn’t this year's only use of gaming techniques

- PMLiVE

Boehringer talks More Health on new blog

Pharma company's US team looks to connect with 'social entrepreneurs'

- PMLiVE

Boehringer takes leukaemia drug volasertib into phase III

Shows positive results in a difficult-to-treat patient population

- PMLiVE

Boehringer launches COPD awareness drive in Japan

Social media campaign will target male smokers’ wives and daughters

- PMLiVE

Bayer’s Xarelto cleared in Europe for pulmonary embolism and DVT prevention

Gives further edge over Boehringer’s anticoagulant Pradaxa

- PMLiVE

Boehringer launches online education portal for hepatitis C

Comes as company moves its interferon-free hep C regimen into phase III

- PMLiVE

Will Boehringer succeed with Syrum?

Time will tell if Boehringer’s bold ambitions for its Facebook game can be fulfilled

- PMLiVE

More action needed to prevent AF-related strokes

Bayer-sponsored report says Europe is heading for a ‘stroke crisis’

- PMLiVE

Boehringer-Lilly win expanded European licence for Trajenta

Type 2 diabetes drug approved as add-on to insulin in adults

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links